期刊文献+

0.5%马来酸右旋噻吗洛尔滴眼液的稳定性 被引量:3

Study on the Stability of 0.5% Timolol Maleate Eye Drops
下载PDF
导出
摘要 目的 :研究马来酸右旋噻吗洛尔滴眼液的稳定性 ,并预测其室温贮存期。方法 :采用紫外分光光度法测定马来酸右旋噻吗洛尔滴眼液含量 ,以初匀速法预测其有效期。结果 :0 5 %马来酸右旋噻吗洛尔滴眼液在室温下 ,有效期仅70d ,而置于5℃冰箱中贮存 ,有效期可达1 2y。结论 :初匀速法预测药品有效期简便、省时、准确 ,适用于医院制剂稳定性研究。 OBJECTIVE:To study the stability of timolol maleate eye drops and predict its storage period at room temperature METHODS:Timolol maleate was determined by UV-spectrophotometry,initial average rate method was used in predicting the expiry term RESULTS:Stability of the 0 5% timolol maleate eye drops was not so good,expiry term predicted at 25℃ was only 70 days,while at 5℃ was as long as 1 2 years CONCLUSIONS:Initial average rate method is rapid,convenient and precise,so it is suitable for stability study of hospital preparations
出处 《中国药房》 CAS CSCD 2002年第8期496-496,共1页 China Pharmacy
关键词 0.5%马来酸右旋噻吗洛尔滴眼液 初匀速法 稳定性 紫外分光光度法 initial average rate method timolol maleate stability
  • 相关文献

参考文献2

  • 1中华人民共和国药典委员会.中国药典(二部).2000版[M].北京:化学工业出版社,2000.附录174.
  • 2李淑芳,张扬,王莹,李京.诺氟沙星滴眼液的稳定性[J].中国医院药学杂志,2000,20(6):347-348. 被引量:8

二级参考文献3

共引文献8

同被引文献15

  • 1庞贻慧 鲁纯素.药物稳定性预测方法的简化-初均速法[J].药学学报,1982,17(3):207-211.
  • 2胡永芳 张鸿燕.紫外分光光度法测定扑尔敏霜剂中扑尔敏的含量[J].甘肃药学,(1):14-14.
  • 3广东省卫生厅.广东省药品标准 [S]: 1987年版:下册[M].,1 187..
  • 4国家药典委员会编.中华人民共国药典(二部) [S]: 2000年版[M].北京:化学工业出版社,2000.附录Ⅳ.
  • 5陈新谦 金有豫.新编药物学 :第 14版[M].北京:人民卫生出版社,1998.563.
  • 6Waland M J, Parikh RS, Thomas R, et al. There is insuficient evi- dence to recommend lens extraction as a treatment for primary open- angle glaucoma: an evidence-based perspective [ J]. Clin Experi- ment Ophthalmol,2012,40(4) :400 -407.
  • 7Sanhu SK,Keswarwani S, Mittal R. Unusual presentation of phaco- lytic glaucoma: simulating microbial keratitis[ J]. Cases Rep Oph- thalmol Med, 2011,2011:850919.
  • 8Yoshikawa K, Kozaki J, Maeda H. Efficacy and safety of brinzo lamide / timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension[J]. Clin Ophthalmol,2014 ,8 :389 - 399.
  • 9Shimizu Y,Nakakura S, Nishiyama M,et al. Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5 % while maintaining the prostaglan- din F2ct analog[ J]. Clin Ophthalmol, 2015,9:475 - 482.
  • 10Lipatov DV,Chlstiakov TA,Kuzmin AG,et al. Evaluation of the ef- fectiveness of Ganfort treatment in patients with secondary neovascu- lar glaucoma associated with diabetes mellitus [ J ]. Vestn Ofalmol, 2014,130(3) :45 -48.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部